Skip to search formSkip to main contentSkip to account menu

SK&F 86466

Known as: SK&F-86466, SKF 86466 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The respiratory effects of stimulation of α2‐adrenergic receptors were studied in spontaneously breathing anaesthetized rats that… 
2001
2001
Abstract. Variations in the measurement of ligand's intrinsic activity between receptor subtypes is a common consequence of… 
2000
2000
Moxonidine is an antihypertensive drug that lowers sympathetic vasomotor tone by stimulating either alpha2-adrenergic (alpha2-AR… 
2000
2000
Activation of the recombinant human α2C‐adrenoceptor (α2C AR) by (−)‐adrenaline in CHO‐K1 cells transiently co‐expressing a… 
Review
1999
Review
1999
Moxonidine is a centrally acting antihypertensive. Its action is mediated by imidazoline I1 receptors located in the rostral… 
1999
1999
Presynaptic, release-inhibiting imidazoline receptors have hitherto been detected mainly under conditions of ongoing α2… 
1990
1990
Hypothermia induced by either clozapine or clonidine in mice was blocked by the alpha 2-adrenergic antagonists yohimbine… 
1990
1990
Hypothermia induced by either clozapine or clonidine in mice was blocked by the α2-adrenergic antagonists yohimbine, idazoxan, CH… 
1984
1984
SK&F 86466, 6-chloro-3-methyl-2, 3, 4, 5-tetrahydro-1H-3-benzazepine, a potent and selective competitive antagonist of the alpha…